TY  - JOUR
AU  - Vicente-Zurdo, David
AU  - Rosales-Conrado, Noelia
AU  - León González, María Eugenia
AU  - Brunetti, Leonardo
AU  - Piemontese, Luca
AU  - Pereira-Santos, A. Raquel
AU  - Cardoso, Sandra M.
AU  - Madrid Albarrán, Yolanda
AU  - Chaves, Silvia
PY  - 2022
DO  - 10.3390/biomedicines10071510
SN  - 2227-9059
UR  - https://hdl.handle.net/20.500.14352/72285
T2  - Biomedicines
AB  - Alzheimer’s disease (AD) is the most serious and prevalent neurodegenerative disorder still without cure. Since its aetiology is diverse, recent research on anti-AD drugs has been focused on multi-target compounds. In this work, seven novel hybrids...
LA  - eng
PB  - MDPI
KW  - Alzheimer’s disease
KW  - multi-target drugs
KW  - rivastigmine
KW  - neurodegenerative
KW  - amyloid aggregation
KW  - acetylcholinesterase
KW  - butyrylcholinesterase
TI  - Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease
TY  - journal article
VL  - 10
ER  -